Avience Biomedicals IPO Live Subscription Status
Real-time subscription data from BSE & NSE with category-wise breakdowns
📈 Building steadily
📈 GMP Today
🎟️ Allotment Status
📄 Full IPO Details
Listed at NSE · Registrar: Skyline Financial Services Pvt. Ltd.
Price: ₹196 - ₹208
Lot: 1200
Min: ₹2,49,600
Period: 18 Jun - 22 Jun
Subscribed
385.40x
Total Demand
₹7,710 Cr
Applications
1,92,952
Subscription (Shares)
| Category | Offered | Applied | Times |
|---|---|---|---|
| QIB | 2,73,600 | 5,38,37,400 | 196.77 |
| NII | 2,07,000 | 12,37,09,800 | 597.63 |
| bNII (>10 Lakh) | 1,38,000 | 9,25,66,800 | 670.77 |
| sNII (2-10 Lakh) | 69,000 | 3,11,43,000 | 451.35 |
| Retail | 4,81,200 | 19,31,32,800 | 401.36 |
| TOTAL | 9,61,800 | 37,06,80,000 | 385.40 |
Application Breakup
| Category | Reserved | Applications | Times |
|---|---|---|---|
| NII | 172 | 31,836 | 185.09 |
| bNII (>10 Lakh) | 115 | 16,492 | 143.41 |
| sNII (2-10 Lakh) | 58 | 15,344 | 264.55 |
| Retail | 401 | 1,60,944 | 401.36 |
| TOTAL | 746 | 1,92,952 | 258.65 |
Subscription (Crores)
| Category | Offered | Demand | Times |
|---|---|---|---|
| QIB | 5.69 | 1,119.82 | 196.77 |
| NII | 4.31 | 2,573.16 | 597.63 |
| bNII (>10 Lakh) | 2.87 | 1,925.39 | 670.77 |
| sNII (2-10 Lakh) | 1.44 | 647.77 | 451.35 |
| Retail | 10.01 | 4,017.16 | 401.36 |
| TOTAL | 20.01 | 7,710.14 | 385.40 |
Subscription by Category
1× = fully subscribed · capped 10×
Estimated Allotment Chance
Retail
0.28%
(401.36x subscribed)
Low chance
S-HNI (2-10L)
0.22%
(451.35x subscribed)
Low chance
B-HNI (>10L)
0.75%
(670.77x subscribed)
Low chance
If 100 retail investors apply, approximately 1 will get allotment.
Estimated from current subscription data, calibrated against published basis-of-allotment results.
Actual allotment depends on the number of applications received and SEBI's allotment rules —
draw of lots for Retail, Employee and NII; proportionate for QIB.
Disclaimer: Subscription data is sourced from BSE and NSE.
Please verify with official exchange websites before making any investment decisions.
This information is for educational purposes only and should not be construed as investment advice.
Avience Biomedicals IPO Subscription — Detailed Analysis
Where Avience Biomedicals Subscription Stands Today
Avience Biomedicals IPO has been subscribed 385.40 times overall — a heavily oversubscribed level that signals strong investor demand and improves the prospects of a positive listing day. A total of 1,92,952 applications have been received so far.
Avience Biomedicals IPO Subscription — FAQs
Avience Biomedicals IPO is currently subscribed 385.40 times overall.
Avience Biomedicals IPO is open for subscription from June 18, 2026 to June 22, 2026.
The price band for Avience Biomedicals IPO is ₹196 - ₹208 per share.
New to subscription data? The hub explains what QIB, NII and Retail mean and how to read the table. For allotment odds from these numbers, see the allotment chances calculator or our IPO allotment process explainer.
Explore More
Quick links to all IPO sections
Open IPO
Live now
Best IPO Today
Top picks
Upcoming IPO
Coming soon
IPO Calendar
Dates & schedule
Closed IPO
Allotment pending
Listed IPO
Listing gains
IPO GMP
Grey market premium
Subscription
Live bidding data
Allotment
Check status
SME IPO
Small & medium
Mainboard IPO
Large cap
Performance
Listing returns
Learn
IPO guides